<DOC>
	<DOCNO>NCT01418508</DOCNO>
	<brief_summary>The purpose study determine whether low protein diet low protein diet supplement keto-/amino acid effective prevent progression chronic kidney disease ( CKD , stage 3b 4 ) .</brief_summary>
	<brief_title>Effects Low Protein Diet Supplemented Keto-/Amino Acid Preventing Progression Chronic Kidney Disease ( CKD ) - ELPD Study</brief_title>
	<detailed_description>Dietary protein restriction represent basic therapeutic approach chronic kidney disease ( CKD ) , reduce accumulation nitrogen catabolic substance , delay progress CKD proteinuria , effect different degree 's protein diet renal progression remain determine . The aim study evaluate efficacy low protein diet α-keto acid tablet retard progress CKD . This randomized , open-label , prospective study , 120 patient meet inclusion exclusion criterion randomize three group ratio 1:1:1 . Group I patient receive low protein diet ( 0.6g/kg BW ) , group II receive low protein diet supplement α-keto acid , group III take low protein diet ( 0.3g/kg BW ) supplement α-keto acid . The change glomerular filtration rate CKD evaluate 1 year treatment .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Patients chronic kidney disease stage 3b 4 ( 15ml/min/1.73m2＜GFR＜45 ml/min/1.73m2 , estimate EPI formula ) receive conservative treatment CKD With diagnosis diabetic mellitus ; Incapable follow study requirement control diet ; Glomerular filtration rate &lt; 15 ml/min/1.73m2 ; Hypercalcemia hyperkalemia ( &gt; normal upper limit ) ; Other serious disease ( eg.heart , lung , brain ) within last 3 month ; Cardiac failure stage IV NYHA ; With cirrhosis liver obvious symptom liver disease , ALT AST two time normal upper limit ; Severe edema serous cavity effusion ; Drug abuse ; Final diagnosis malignant tumor ; Receiving longterm systematic steroid hormone immunosuppressive agent ( eg . Cyclophosphamidum , Cyclosporine , Prograf , Azathioprine ) treatment ; Gestation already , prepares pregnant period trial , lactate woman ; Participate product clinical trial within 30 day prior trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>